| Literature DB >> 10856240 |
M Kurokawa1, K Mitani, T Yamagata, T Takahashi, K Izutsu, S Ogawa, T Moriguchi, E Nishida, Y Yazaki, H Hirai.
Abstract
Evi-1 encodes a nuclear protein involved in leukemic transformation of hematopoietic cells. Evi-1 possesses two sets of zinc finger motifs separated into two domains, and its characteristics as a transcriptional regulator have been described. Here we show that Evi-1 acts as an inhibitor of c-Jun N-terminal kinase (JNK), a class of mitogen-activated protein kinases implicated in stress responses of cells. Evi-1 physically interacts with JNK, although it does not affect its phosphorylation. This interaction is required for inhibition of JNK. Evi-1 protects cells from stress-induced cell death with dependence on the ability to inhibit JNK. These results reveal a novel function of Evi-1, which provides evidence for inhibition of JNK by a nuclear oncogene product. Evi-1 blocks cell death by selectively inhibiting JNK, thereby contributing to oncogenic transformation of cells.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10856240 PMCID: PMC203342 DOI: 10.1093/emboj/19.12.2958
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598